Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
Cycle Care: Egal raises $1M for its ‘Pads on a Roll’.
UK-based virtual dermatology startup Skin + Me adds £10M in Series B funding.
New fund spearheaded by Reckitt mints NFT collection to accelerate Africa’s women-led startups tackling health challenges.
Consumer biotech company Tally Health launches a new platform aimed at extending longevity.
Joi launches in the US to help women manage their health holistically.
New research suggests endometriosis could be controlled with monthly injections.
New study by MyOme suggests cross-ancestry polygenic risk score improves breast cancer prediction.
Ovia Health enhances its digital platform by adding menopause tracking features.
In the Know
Innovation in Endometriosis Diagnostics and Care (Femtech Insider)
Femtech Investment Round-up: February 2023 (Femtech Insider)
Why investing in women’s health is impact investing (FastCompany)
Gender bias poses a challenge to FemTech fundraising in MENA (Zawya)
‘Gender trolling’ is curbing women’s rights – and making money for digital platforms (Guardian)
4 hot women’s health subcategories (Axios)
Redefining sustainability in healthcare: putting patients before profit (STAT News)
Doubling NIH Funding for Women’s Health Would Yield Substantial Return on Investment (Rand Blog)
The Lure of Self-Experimentation (Neo.Life)
Why Silicon Valley Is Failing to Address Health Equity (Forbes)